Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Streptavidin-Cy3: High-Sensitivity Fluorescent Biotin Det...

    2026-03-11

    Streptavidin-Cy3: High-Sensitivity Fluorescent Biotin Detection Reagent

    Executive Summary: Streptavidin-Cy3 is a conjugate of tetrameric streptavidin (52,800 Da) and the Cy3 fluorophore, optimized for detection of biotinylated targets with a maximum excitation at 554 nm and emission at 568 nm, facilitating robust and specific fluorescent labeling across diverse assay platforms (APExBIO). Each streptavidin molecule binds up to four biotin molecules with femtomolar affinity, ensuring irreversible detection in immunohistochemistry, immunofluorescence, in situ hybridization, and flow cytometry (dznep.com). The reagent is stable at 2–8°C and must be protected from light; freezing is contraindicated to maintain fluorescence intensity. Streptavidin-Cy3 has demonstrated exceptional reliability in high-sensitivity cancer metastasis research, especially for visualizing biomolecular signatures such as those implicated in nasopharyngeal carcinoma (AJCR 2023). Compared to alternative detection systems, the K1079 kit from APExBIO offers reproducible, bright labeling suitable for advanced translational workflows (perylene-azide.com).

    Biological Rationale

    Biotin-streptavidin binding is among the strongest non-covalent interactions in biology, with a dissociation constant (Kd) of approximately 10-14 to 10-15 M (APExBIO). This interaction enables robust capture and detection of biotinylated molecules in complex biological samples. The Cy3 fluorophore is a cyanine dye with peak excitation at 554 nm and emission at 568 nm, offering high quantum yield and photostability in standard fluorescence microscopy filter sets (dznep.com). In cancer research, sensitive detection of biomolecular changes—such as those seen in nasopharyngeal carcinoma metastasis—is crucial for understanding disease mechanisms and developing targeted diagnostics (AJCR 2023).

    Streptavidin-Cy3 conjugates have become central to workflows requiring visualization of biotinylated antibodies, nucleic acids, or proteins. Their use in immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), in situ hybridization (ISH), and flow cytometry has enabled precise, multiplexed detection of disease markers and pathway intermediates. The stability and brightness of the Cy3 label support reproducible, quantitative imaging and analysis (perylene-azide.com).

    Mechanism of Action of Streptavidin-Cy3

    Streptavidin is a homo-tetrameric protein capable of binding four biotin molecules per tetramer, each with near-irreversible affinity (APExBIO). The Cy3 fluorophore is covalently attached, enabling direct fluorescent readout of biotinylated targets. Upon incubation with a biotinylated primary or secondary antibody (or other biotin-labeled biomolecule), Streptavidin-Cy3 binds specifically and with minimal off-target background.

    The Cy3 moiety absorbs light maximally at 554 nm and emits at 568 nm, providing a bright, photostable fluorescent signal visible with standard TRITC or Cy3 filter sets (dznep.com). This enables precise localization and quantification of biotinylated molecules in fixed or live-cell samples. The conjugate's molecular weight (52,800 Da) and structural stability afford compatibility with a wide range of buffers and fixation protocols, provided that samples are protected from light and not frozen.

    Evidence & Benchmarks

    • Streptavidin-Cy3 demonstrates high-specificity recognition of biotinylated targets, with Kd < 10-14 M and minimal non-specific binding under standard immunofluorescence conditions (APExBIO).
    • Cy3 fluorescence is stable and bright under repeated excitation, with a quantum yield of 0.15–0.4, and is compatible with common excitation (554 nm) and emission (568 nm) filter sets (dznep.com).
    • In cancer metastasis studies, Streptavidin-Cy3 enabled sensitive detection of biotinylated nucleic acids and proteins, facilitating visualization of molecular changes (e.g., seRNA-NPCm and NDRG1) in nasopharyngeal carcinoma tissue sections (AJCR 2023).
    • APExBIO’s K1079 kit outperformed alternative biotin detection reagents in head-to-head workflow comparisons, delivering lower background and higher signal-to-noise ratios in IHC and IF (perylene-azide.com).
    • Streptavidin-Cy3 is validated for use in multi-step protocols, including sequential ISH and immunofluorescence with preservation of both nucleic acid and protein epitopes (streptavidin-ap.com).

    Applications, Limits & Misconceptions

    Streptavidin-Cy3 is designed for high-sensitivity detection of biotinylated antibodies, nucleic acids, and proteins in diverse sample types. Its use spans basic and translational research, including:

    • Immunohistochemistry (IHC) of tissue sections to localize protein markers.
    • Immunofluorescence (IF) and immunocytochemistry (ICC) for cellular and subcellular localization.
    • In situ hybridization (ISH) for detecting biotinylated nucleic acid probes.
    • Flow cytometry for quantitative biotin detection on cell surfaces or intracellularly.

    In contrast to previous reviews that focused on general performance, this article details storage parameters, direct cancer study benchmarks, and troubleshooting, providing a resource for optimizing advanced translational workflows.

    Common Pitfalls or Misconceptions

    • Freezing Streptavidin-Cy3: Freezing the reagent leads to loss of fluorescence intensity and potential aggregation (APExBIO).
    • Photobleaching: Extended exposure to light reduces Cy3 fluorescence. Samples and reagents must be protected from light throughout storage and use.
    • Non-specific binding in high-biotin environments: Excess endogenous biotin (e.g., in certain tissues) can compete, reducing signal-to-noise ratio.
    • Filter set mismatch: Using filter sets incompatible with Cy3 wavelengths (excitation 554 nm / emission 568 nm) results in loss of detectable signal.
    • Assay incompatibility: Not suitable for protocols requiring denaturation conditions that disrupt streptavidin structure or Cy3 fluorescence.

    For expanded troubleshooting and protocol enhancements, see this detailed guide, which this article updates by adding new clinical benchmarks and storage insights.

    Workflow Integration & Parameters

    Incorporating Streptavidin-Cy3 into immunoassays involves several critical parameters:

    • Concentration: Optimal working concentrations are 1–5 µg/mL for most IHC/IF/ISH protocols; titration is recommended.
    • Buffer compatibility: Works in PBS, TBS, and commonly used blocking agents; avoid reducing agents and detergents above 0.1%.
    • Incubation: 30–60 min at room temperature; longer incubations can increase background.
    • Washing: Rigorous washing (3–5x with buffer) minimizes non-specific background.
    • Storage: Store at 2–8°C, protected from light; do not freeze (APExBIO).

    Protocol steps should be adapted to sample type and detection sensitivity required. For translational researchers targeting rare cell populations or subtle molecular changes, Streptavidin-Cy3 provides the sensitivity to detect low-abundance biotinylated targets. This article extends the mechanistic focus of Illuminating Metastatic Pathways by detailing hands-on integration parameters and addressing clinical validation in nasopharyngeal carcinoma.

    Conclusion & Outlook

    Streptavidin-Cy3, supplied by APExBIO, is a benchmark fluorescent probe for sensitive biotin detection in modern immunohistochemistry, immunofluorescence, in situ hybridization, and flow cytometry. Its robust biotin-streptavidin binding, bright Cy3 emission, and stability parameters enable reproducible, high-clarity labeling essential for translational research, including cancer metastasis studies. As biotin-based multiplexing and spatial omics advance, Streptavidin-Cy3 is positioned to remain a core reagent for high-sensitivity, machine-readable biomolecular detection (dznep.com, iy-5511.com).